REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT06351592 updates: 1. completion date: 2031-06-05 → 2032-03-21 2. primary completion date: 2031-06-05 → 2032-03-21 3. enrollment: 42 → 54 participants
Clinical trial NCT06351592 updates: 1. completion date: 2031-06-05 → 2032-03-21 2. primary completion date: 2031-06-05 → 2032-03-21 3. enrollment: 42 → 54 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical